Analysis of expression of PTEN/PI3 K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
Cedrés, S, Ponce-Aix, S, Pardo, N, Navarro-Mendivil, A, Martinez-Marti, A, Zugazagoitia, J, Sansano, I, Montoro, M.A, Enguita, A, Felip, E
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Get full text
Journal Article
Phase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression
Joerger, M., Takahashi, S., Sayehli, C.M., Slosarczyk, S., Navarro Mendivil, A., Cassier, P.A., Nogai, H., Zhang, C., Sei, F., Bender, S., Ellinghaus, P., Tahara, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Maintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study
Thomas, M., Ponce Aix, S., Navarro Mendivil, A., Riera Knorrenschild, J., Schmidt, M., Wiegert, E., Kapp, K., Mauri, C., Domine Gomez, M., Kollmeier, J., Sadjadian, P., Fröhling, K.-P., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S., Sanso, M., Hernando-Calvo, A., Callejo, A., Pardo Aranda, N., Navarro Mendivil, A., Martinez, A., Remon, J., Miquel, J.M., Rodriguez, G., Monton, V., Villacampa, G., Dienstmann, R., Vivancos, A., Felip Font, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Immune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?
Matos Garcia, I., Azaro, A., Viaplana, C., Hierro, C., Martin-Liberal, J., Brana, I., Gardeazabal, I., Gomila, P., Vieito Villar, M., Ochoa De Olza Amat, M., Elez Fernandez, E., Oliveira, M., Oaknin, A., Verdaguer, H., Navarro Mendivil, A., Alsina, M., Tabernero, J., Macarulla Mercade, T., Dienstmann, R., Garralda, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
Cedrés, S., Ponce-Aix, S., Pardo-Aranda, N., Navarro-Mendivil, A., Martinez-Marti, A., Zugazagoitia, J., Sansano, I., Montoro, M.A., Enguita, A., Felip, E.
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Get full text
Journal Article
1751TiPCLEPSIDRA trial: A pilot, biomarker-guided study to assess safety, tolerability, dose finding and efficacy of iadademstat in combination with platinum-etoposide in patients with relapsed, extensive-stage small cell lung cancer
Navarro Mendivil, A F, Gutierrez, S, Maes, T, Bullock, R, Ropacki, M, Buesa, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
MA12.03 Prognostic Value of Clinical Staging According to TNM in SCLC Patients; A Real-World SEER Database Analysis
Arriola Aperribay, E., Trigo Pérez, J., Sánchez Gastaldo, A., Navarro Mendivil, A., Crama, L., Ruiz Gracia, P., Ponce Aix, S.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
1056PDPhase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression
Joerger, M, Takahashi, S, Sayehli, C M, Slosarczyk, S, Navarro Mendivil, A, Cassier, P A, Nogai, H, Zhang, C, Sei, F, Bender, S, Ellinghaus, P, Tahara, M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P48.14 RESILIENT Part 2: A phase 3 Study of Liposomal Irinotecan in Patients with Small-Cell Lung Cancer in the Second-Line Setting
Paz-Ares, L., Spigel, D.R., Chen, Y., Jove, M., Juan-Vidal, O., Rich, P., Hayes, T., Calderón, V. Gutiérrez, Caro, R.B., Mendivil, A. Navarro, Dowlati, A., Zhang, B., Moore, Y., Wang, T., Kokhreidze, J., Ponce, S., Bunn, P.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
1806PDMultiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S, Sanso, M, Hernando-Calvo, A, Callejo, A, Pardo Aranda, N, Navarro Mendivil, A, Martinez, A, Remon, J, Miquel, J M, Rodriguez, G, Monton, V, Villacampa, G, Dienstmann, R, Vivancos, A, Felip Font, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study
Thomas, M, Ponce Aix, S, Navarro Mendivil, A, Riera Knorrenschild, J, Schmidt, M, Wiegert, E, Kapp, K, Mauri, C, Domine Gomez, M, Kollmeier, J, Sadjadian, P, Fröhling, K-P, Huber, R M, Wolf, M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Brain metastases (BM) development in molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
Cedres, S., Pardo, N., Navarro-Mendivil, A., Martinez, A., Martinez de Castro, A., Remon, J., Amair, F., Zeron, J., Vilaro, M., Felip, E.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m
Aranda, N. Pardo, Ruiz, F., Marti, A. Martinez, Cedres, S., Mendivil, A. Navarro, fuente, Idela, de Castro, A. Martinez, Vivancos, A., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Immune surveillance reactivation to improve overall survival in small cell lung cancer (SCLC): The randomized IMPULSE study
Thomas, M., Carter, R., Aix, S. Ponce, Riera-Knorrenschild, J., Mendivil, A. Navarro, Domine, M., Kollmeier, J., Sadjadian, P., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Top-line data from the randomized phase 2 IMPULSE study in small-cell lung cancer (SCLC): Immunotherapeutic maintenance treatment with lefitolimod
Thomas, M., Ponce-Aix, S., Navarro Mendivil, A., Riera Knorrenschild, J., Schmidt, M., Krikow, M., Wiegert, E., Domine Gomez, M., Kollmeier, J., Sadjadian, P., Fröhling, K.P., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
110PImmune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?
Matos Garcia, I, Azaro, A, Viaplana, C, Hierro, C, Martin-Liberal, J, Brana, I, Gardeazabal, I, Gomila, P, Vieito Villar, M, Ochoa De Olza Amat, M, Elez Fernandez, E, Oliveira, M, Oaknin, A, Verdaguer, H, Navarro Mendivil, A, Alsina, M, Tabernero, J, Macarulla Mercade, T, Dienstmann, R, Garralda, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Immunomodulatory switch maintenance therapy to improve overall survival in small cell lung cancer (SCLC): The randomized IMPULSE study
Thomas, M., Zurlo, A., Carter, R., Aix, S. Ponce, Knorrenschild, J. Riera, Mendivil, A. Navarro, Domine, M., Kollmeier, J., Huber, R.M., Wolf, M.
Published in Annals of oncology (01.11.2015)
Published in Annals of oncology (01.11.2015)
Get full text
Journal Article
A phase Ib study of lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with carboplatin and paclitaxel as 1st-line treatment in patients with squamous non-small cell lung cancer
Cejalvo, J.M., Fleitas, T., Felip, E., Mendivil, A. Navarro, Martinez-Garcia, M., Taus, A., Leighl, N., Lassen, U., Soerensen, M. Mau, Adessi, C., Michielin, F., Jacob, W., James, I., Ceppi, M., Weisser, M., Cervantes, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
Cedres, S., Aranda, N. Pardo, de Castro, A. Martinez, Mendivil, A. Navarro, Marti, A. Martinez, Ortiz, C., Racca, F., Vilaro, M., Carbonell, L., Piera, A., fuente, Idela, Felip, E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article